Neurology
Vyvgart Hytrulo Challenges the Step Therapy Model in Treatment-Naive CIDP
ADHERE post hoc data at AAN 2026 show 87.5% of treatment-naive CIDP patients respond early to Vyvgart Hytrulo, challenging IVIG step therapy.
Rayan Salih · April 30, 2026 · 7 min